Ihosvany Fernández-Bello, PhD (he/him/his)

Postdoctoral Researcher
Hemostasis and Thrombosis Unit, Regional University Hospital of Málaga, IBIMA, Málaga, Spain.
Málaga, Andalucia, Spain

Ihosvany Fernández is a postdoctoral researcher who works in the Thrombosis and Haemostasis Unit of the Regional University Hospital of Málaga-IBIMA and in the General University Hospital of Alicante. Dr. Fernández works mainly in the study of congenital hemophilia and the application of techniques for the global study of hemostasis in this group of patients. He is currently working on acquired hemophilia for the identification of prognostic biomarkers, on the study of the joint status of patients with non-severe hemophilia, and on primary immune thrombocytopenia.

Presentation(s):

• PB0059 - Thrombomodulin resistance as a novel pathway involved in the hypercoagulable state of COVID-19 patients

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB1275 - Multicenter and cross-sectional study of joint damage of patients with non-severe hemophilia: A "Mediterranean Group" study

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1290 - Successful very low dose immune tolerance induction with albutrepenonacog alfa in a severe hemophilia B child with anaphylactic reaction to factor IX

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1294 - FIRST REPORTED CASE OF CARDIAC SURGERY IN A PATIENT WITH HEMOPHILIA B ON TREATMENT WITH ALBUTREPENONACOG ALFA (rIX-FP).

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1326 - Real-world data on correlation between emicizumab plasma levels, ex-vivo procoagulant profile and spontaneous joint annualized bleeding rate of patients on emicizumab prophylaxis

  Tuesday, June 27, 2023
  18:30 – 19:30 ET